And I still maintain, we do not know enough about any of the vaccines, especially the Chinese/Russian varieties, to make informed decisions in conjunction with one's own physician.
But if it gives people a false sense of security.............it does provide some benefit.....................so roll up those sleeves.............because the best vaccine you can get.........is the one you can get lol................and you will likely be vaccinated again..........as new strains and the protective bubble you think you are in............wears off.
Respectfully,
Playacaribe2
The number of COVID-19 patients under 40 in intensive care in Brazil surpassed older groups last month, a researcher said Sunday, amid a deadly surge driven partly by a new coronavirus variant.
The number of people aged 39 or younger in intensive care units with COVID-19 in March rose sharply to more than 11,000, or 52.2 percent of the total, said the Brazilian ICU Project.
That was up from 14.6 percent of total ICU patients early in the pandemic and around 45 percent from September through February.
"Previously, this was a population that would typically only develop a less-severe form of the disease and would not need intensive care. So the increase for this age group is very significant," said Dr. Ederlon Rezende, co-coordinator of the project, an initiative of the Brazilian Association of Intensive Medicine (AMIB).
He said various factors could be driving the increase.
Patients over 80, who fell from 13.6 percent to 7.8 percent of the total in Brazil's ICUs in March, are now largely vaccinated.
Young people are also more likely to expose themselves to the virus, whether because they have to leave home to work or believe they are less vulnerable, he said.
Another factor may be the new Brazilian variant, known as P1, which experts say is partly responsible for the country's COVID-19 death toll exploding in March.
The numbers suggest that P1, which can re-infect people who have had the original strain of the virus, may also be more virulent, Rezende said.
"The patients arriving in ICUs now are younger, have no pre-existing conditions and are developing more severe cases of the virus, too," he told AFP.
The number of ICU patients without pre-existing conditions increased by nearly a third in March, to 30.3 percent of the total.
The number of people aged 39 or younger in intensive care units with COVID-19 in March rose sharply to more than 11,000.
news.abs-cbn.com
Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil
As potentially more dangerous coronavirus variants spread worldwide, scientists and clinicians have raced to discover how well the available COVID-19 vaccines protect against the mutant strains. Preliminary results from a large study of health care workers now suggest one dose of CoronaVac, a vaccine developed by a Chinese company, is still about 50% effective against symptomatic COVID-19 in a Brazilian city where more than three-fourths of new cases are caused by the highly transmissible variant known as P.1.
That real-world protection is about the same level clinical trials saw with two doses of CoronaVac against the standard, or “wild type,” pandemic coronavirus in the country, suggesting the variant’s mutations have not increased SARS-CoV-2’s ability to evade vaccine-evoked immune responses.
The number of people aged 39 or younger in intensive care units with COVID-19 in March rose sharply to more than 11,000.
news.abs-cbn.com
